SNTI - Financial Reports List - Senti Biosciences, Inc. - IntrinsicAlpha

Senti Biosciences, Inc. SNTI

Healthcare - Biotechnology - NASDAQ - US

$ 3.0915

0.625 %

$ 80.6 M

Market Cap

8.7

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q1	8-K	2025-03-31	0.00%	-16.52%	-0.59%
Quarterly Report	Q4	8-K	2024-12-31	1658.56%	96.74%	12.26%
Annual Report	FY	10-K	2024-12-31	0.00%	43.19%	34.17%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-93.43%	65.32%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	40.08%	31.98%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	35.31%	17.81%
Quarterly Report	Q4	8-K	2023-12-31	464.41%	-2.78%	7.94%
Annual Report	FY	10-K	2023-12-31	-40.25%	-59.63%	-31.29%
Quarterly Report	Q3	8-K	2023-09-30	-85.56%	10.32%	-156.81%
Quarterly Report	Q2	8-K	2023-06-30	-15.43%	-61.85%	9.81%

1